21 – 30 of 46
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Re : A. Gordon Robertson, Clarice S. Groeneveld, Brian Jordan, et al. Identification of Differential Tumor Subtypes of T1 Bladder Cancer. Eur Urol. In press. http://doi.org/10.1016/j.eururo.2020.06.048
(
- Contribution to journal › Letter
-
Mark
Recurring urothelial carcinomas show genomic rearrangements incompatible with a direct relationship
(
- Contribution to journal › Article
- 2019
-
Mark
Re : Tuan Zea Tan, Mathieu Rouanne, Kien Thiam Tan, Ruby Yun-Ju Huang, Jean-Paul Thiery. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors. Eur Urol 2019;75:423–32
(
- Contribution to journal › Letter
-
Mark
Molecular pathology of the luminal class of urothelial tumors
(
- Contribution to journal › Article
-
Mark
Molecular subtypes applied to a population-based modern cystectomy series do not predict cancer-specific survival
(
- Contribution to journal › Article
- 2018
-
Mark
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
(
- Contribution to journal › Article
-
Mark
Molecular subtype classification of urothelial carcinoma in Lynch syndrome
(
- Contribution to journal › Article
-
Mark
Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
(
- Contribution to journal › Article
-
Mark
Promoter-associated proteins of EPAS1 identified by enChIP-MS – A putative role of HDX as a negative regulator
(
- Contribution to journal › Article
-
Mark
Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases
(
- Contribution to journal › Article